In this study, we investigated treatment of unmutated BCR-ABL and mutated BCR-ABL transduced murine cells as well as primary CML cells from patients with 1R-Chl alone or in combination with imatinib. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.